BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 22398741)

  • 1. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
    Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
    J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the risk factors for local recurrence of giant cell tumor of long bone].
    Xu H; Niu X
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):465-8. PubMed ID: 25241792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
    Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
    J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
    Li X; Guo W; Yang Y; Wei R; DU ZY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
    Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
    Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis?
    van der Heijden L; van de Sande MA; Heineken AC; Fiocco M; Nelissen RG; Dijkstra PD
    J Bone Joint Surg Am; 2013 Nov; 95(21):e159. PubMed ID: 24196471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of giant cell tumors with pathological fracture around the knee].
    Liu WF; Yang FJ; Li Y; Li B; Hao L; Niu XH
    Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):677-686. PubMed ID: 30157574
    [No Abstract]   [Full Text] [Related]  

  • 13. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
    Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
    Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
    Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
    Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
    Cao W; Ye Z; Lin N; Liu M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence Rates and Risk Factors for Primary Giant Cell Tumors around the Knee: A Multicentre Retrospective Study in China.
    Hu P; Zhao L; Zhang H; Yu X; Wang Z; Ye Z; Wu S; Guo S; Zhang G; Wang J; Ning X; Hu Y; Zhang Y
    Sci Rep; 2016 Nov; 6():36332. PubMed ID: 27827384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant cell tumor of bone: are we stratifying results appropriately?
    Kremen TJ; Bernthal NM; Eckardt MA; Eckardt JJ
    Clin Orthop Relat Res; 2012 Mar; 470(3):677-83. PubMed ID: 22125240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell tumor of long bone: a Canadian Sarcoma Group study.
    Turcotte RE; Wunder JS; Isler MH; Bell RS; Schachar N; Masri BA; Moreau G; Davis AM;
    Clin Orthop Relat Res; 2002 Apr; (397):248-58. PubMed ID: 11953616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint preservation after extensive curettage of knee giant cell tumors.
    Ayerza MA; Aponte-Tinao LA; Farfalli GL; Restrepo CA; Muscolo DL
    Clin Orthop Relat Res; 2009 Nov; 467(11):2845-51. PubMed ID: 19513798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.